ONBOARD Program for Type 1 Diabetes (ONBOARD Trial)
Recruiting in Palo Alto (17 mi)
Overseen ByMolly Tanenbaum, PhD
Age: 18 - 65
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Molly Tanenbaum
No Placebo Group
Trial Summary
What is the purpose of this trial?This study is a comprehensive, multicomponent behavioral intervention package (ONBOARD; OvercomiNg Barriers \& Obstacles to Adopting Diabetes Devices). ONBOARD will provide adults with T1D the skills to maximize benefit and minimize daily interference from barriers associated with Continuous Glucose Monitoring (CGM) and increase readiness for closed loop.
Eligibility Criteria
The ONBOARD trial is for English-speaking adults aged 18-50 with type 1 diabetes who haven't been using Continuous Glucose Monitoring (CGM) regularly in the past 6 months. It's not suitable for those with medical or neurological disorders that could affect their participation as judged by the study team.Inclusion Criteria
I am between 18 and 50 years old.
I have been diagnosed with type 1 diabetes.
Participant Groups
ONBOARD is a behavioral intervention designed to help adults with type 1 diabetes overcome barriers to using CGM devices and prepare them for closed loop systems, which automate insulin delivery based on glucose levels.
2Treatment groups
Experimental Treatment
Active Control
Group I: ONBOARD Intervention GroupExperimental Treatment1 Intervention
Those randomized to the ONBOARD group will receive 12 weeks of CGM supplies and provide hemoglobin A1c values, data downloads, and survey responses during various time points in the study. They will also receive the intervention which consists of four 60-minute sessions with study interventionist, held 2 weeks apart.
Group II: CGM Only GroupActive Control1 Intervention
Those randomized to the CGM Only group will not receive the ONBOARD intervention during their 12-month participation in the study. There will only receive 12 weeks of CGM supplies and provide hemoglobin A1c values, data downloads, and survey responses during various time points in the study.
Find A Clinic Near You
Research locations nearbySelect from list below to view details:
Stanford UniversityStanford, CA
Loading ...
Who is running the clinical trial?
Molly TanenbaumLead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Collaborator